Hartley Dylan

Chief Scientific OfficerOnKure Therapeutics, Inc. (OKUR) · full profile →Form 4 · filed Aug 11, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2026Grant(A)50K$050K
Aug 7, 2026Disposed to issuer(D)138K0
Aug 7, 2026Grant(A)138K138K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002037442-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about OKUR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0002037442-26-000002"
Ask your agent
Use Arkolith to summarize insider buying and selling at OnKure Therapeutics, Inc.
over the last 90 days and cite the filings.